Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600196 Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.

Closed 07-23 15:00:00

23.71

-0.26

-1.08%

High23.84	Low23.47	Vol20.72M
Open23.64	D1 Closing23.97	Amplitude1.54%
Mkt Cap63.31B	Tradable Cap50.22B	Total Shares2.67B
T/O490.00M	T/O Rate0.98%	Tradable Shares2.12B
P/B1.29	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.","latestPrice":23.71,"timestamp":1784790000000,"preClose":23.97,"halted":0,"volume":20718584,"delay":0,"changeRate":-0.0108,"floatShares":2118000000,"shares":2670000000,"eps":1.3019,"marketStatus":"Closed","change":-0.26,"latestTime":"07-23 15:00:00","open":23.64,"high":23.84,"low":23.47,"amount":490000000,"amplitude":0.0154,"askPrice":23.72,"askSize":768,"bidPrice":23.71,"bidSize":322,"shortable":0,"etf":0,"ttmEps":1.3019,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":5,"adr":0,"adjPreClose":23.97,"symbolType":"stock","openAndCloseTimeList":[[1784770200000,1784777400000],[1784782800000,1784790000000]],"highLimit":26.37,"lowLimit":21.57,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2670429325,"isCdr":false,"pbRate":1.29,"roa":"--","peRate":18.211844,"roe":"1.78%","epsLYR":1.27,"committee":-0.002077,"marketValue":63316000000,"turnoverRate":0.0098,"status":1,"hkstockBrief":{"symbol":"02196","market":"HK","secType":"STK","nameCN":"FOSUN PHARMA","latestPrice":16.47,"timestamp":1784794086004,"preClose":16.46,"halted":0,"volume":1331660,"delay":0,"premium":"-40.02"},"floatMarketCap":50229000000},"requestUrl":"/m/hq/s/600196/tweets","defaultTab":"tweets","newsList":[{"id":"2653758736","title":"Sinopharm Group Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2653758736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653758736?lang=en_us&edition=fundamental","pubTime":"2026-07-22 16:32","pubTimestamp":1784709120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 1.9% to 16.99 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24892.66.This was the stock's second consecutive day of losses.Sinopharm Group Co. Ltd. closed 24% short of its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.1%.Trading volume totaled 5.1 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 22, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0028","BK4175","01099","BK0175","LU0640798160.USD","SHTDY","BK1191","LU1115378108.SGD","02196","BK0183","600196","BK1593","BK0239","BK1500","BK0187","BK0196","BK0096","BK1197","BK0012","BK0188","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653227067","title":"Sinopharm Group Stock Slides 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2653227067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653227067?lang=en_us&edition=fundamental","pubTime":"2026-07-21 16:31","pubTimestamp":1784622660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 1.7% to 17.32 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 25132.29.Sinopharm Group Co. Ltd. closed 22% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.1%.Trading volume totaled 6.7 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 21, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","02196","LU1115378108.SGD","BK0060","01099","BK1515","BK0196","BK0239","SHTDY","BK1191","BK0012","BK0096","BK0183","BK0188","BK1500","LU0640798160.USD","BK1593","BK1197","600196","BK4175","BK0028","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102125154","title":"Fosun Pharma Achieves Fourth Consecutive Year on China's Best Managed Companies List","url":"https://stock-news.laohu8.com/highlight/detail?id=1102125154","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102125154?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:11","pubTimestamp":1784542270,"startTime":"0","endTime":"0","summary":"On July 17, 2026, the results of the eighth China Best Managed Companies (BMC) project, jointly organized by Deloitte China, the Hong Kong University of Science and Technology Business School, and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1593","BK0183","BK0012","BK0028","BK0188","BK0175","BK0187","BK1515","BK0196","BK1191","BK0096","BK0060","600196","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651417347","title":"Sinopharm Group Stock Climbs 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2651417347","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651417347?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:33","pubTimestamp":1784190780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rose 2.1% to 17.81 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.3% to 25008.60.This was the stock's fifth consecutive day of gains.Sinopharm Group Co. Ltd. closed 20% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 2.2%.Trading volume totaled 4.9 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 16, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0187","01099","BK0012","BK1500","BK1515","BK1191","BK0060","BK0239","BK4175","LU0640798160.USD","BK1593","BK1197","BK0028","02196","BK0196","LU1115378108.SGD","BK0175","SHTDY","600196","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454815","title":"Shanghai Fosun Pharma - Unit Got Approval from Nmpa China for Clinical Trial of Fxr0906 for Treatment of Hypertriglyceridemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651454815?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:15","pubTimestamp":1784110505,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0060","BK1593","BK0175","BK0183","BK0187","BK0239","BK1515","BK0012","BK0096","BK1191","600196","BK0196","BK0028","BK0188","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651548374","title":"Fosun Pharma Shenzhen Wins China Approval to Start Phase I Trial of Fxr0906 for Hypertriglyceridemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2651548374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651548374?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:14","pubTimestamp":1784110492,"startTime":"0","endTime":"0","summary":"Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemiaFosun Pharma (Shenzhen) won Chinese regulator clearance to start Phase I trials of FXR0906 for hyper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL3bD3Mn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0196","BK0188","BK0096","BK0175","BK0239","BK0060","600196","BK0183","BK0187","BK1230","00656","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123458410","title":"Fosun Pharma's Subsidiary Receives Approval for FXR0906 Injection Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1123458410","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123458410?lang=en_us&edition=fundamental","pubTime":"2026-07-15 17:50","pubTimestamp":1784109024,"startTime":"0","endTime":"0","summary":"An announcement from Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH) reveals that its controlling subsidiary, Fosun Pharma Industrial Development (Shenzhen) Co., Ltd., has received...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BMED","BK0096","BK0183","BK1515","600196","BK1191","IBBQ","BK0175","BK0187","BK0028","BK0196","BK0012","BK0239","BK0188","02196","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651145306","title":"Sinopharm Group Stock Rises 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2651145306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651145306?lang=en_us&edition=fundamental","pubTime":"2026-07-15 16:32","pubTimestamp":1784104320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 2.6% to 17.45 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.4% to 24681.10.This was the stock's fourth consecutive day of gains.Sinopharm Group Co. Ltd. closed 22% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 2.7%.Trading volume totaled 5.2 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 15, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","LU1115378108.SGD","BK0187","BK4175","01099","BK1197","BK1500","BK0028","BK0060","600196","02196","BK0239","LU0640798160.USD","BK0096","BK0183","BK0188","SHTDY","BK0012","BK0175","BK0196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650942719","title":"Sinopharm Group Stock Slides 3.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2650942719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650942719?lang=en_us&edition=fundamental","pubTime":"2026-07-09 16:31","pubTimestamp":1783585860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 3.0% to 16.66 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.7% to 24030.18.Sinopharm Group Co. Ltd. closed 25% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 2.1%.Trading volume totaled 6.9 million shares, compared to the 50-day average of 7.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 09, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","600196","BK0175","BK1515","BK0028","BK0187","01099","BK4175","SHTDY","BK1197","BK0060","BK1191","BK1593","LU0640798160.USD","BK0096","02196","BK1500","BK0012","BK0239","BK0183","LU1115378108.SGD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649642982","title":"Sinopharm Group Stock Advances 3.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2649642982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649642982?lang=en_us&edition=fundamental","pubTime":"2026-07-06 16:32","pubTimestamp":1783326720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rose 3.0% to 17.24 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.1% to 23616.32.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 23% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 1.1%.Trading volume totaled 4.9 million shares, compared to the 50-day average of 7.1 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 06, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SHTDY","BK0096","02196","BK0175","600196","BK0028","BK0196","LU1115378108.SGD","BK1191","BK1515","BK0183","BK0187","BK0239","BK1593","BK0060","BK1500","BK4175","01099","BK0012","BK0188","LU0640798160.USD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648654740","title":"Sinopharm Group Stock Climbs 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2648654740","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648654740?lang=en_us&edition=fundamental","pubTime":"2026-07-03 16:33","pubTimestamp":1783067580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.9% to 16.74 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.3% to 23350.03.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 25% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 2.9%.Trading volume totaled 4.9 million shares, compared to the 50-day average of 7.0 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 03, 2026 04:33 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK1191","BK0060","SHTDY","LU0640798160.USD","BK0028","600196","LU1115378108.SGD","BK1593","BK0175","BK0239","BK0012","BK0188","BK0187","BK0183","BK1500","BK4175","01099","02196","BK1515","BK1197","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648465480","title":"Shanghai Fosun Pharma Says Drug Registration Application for Shaoyao Gancao Tang Granules Approved by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2648465480","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648465480?lang=en_us&edition=fundamental","pubTime":"2026-07-03 16:13","pubTimestamp":1783066391,"startTime":"0","endTime":"0","summary":"June 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::*DRUG REGISTRATION APPLICATION FOR SHAOYAO GANCAO TANG GRANULES APPROVED BY NMPA*Further company coverage: 600196.SS* ((Reut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nRSDb09nLw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0028","600196","BK0196","BK0012","BK0096","BK0187","00656","BK1230","BK0175","BK0239","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648508694","title":"Sinopharm Group Stock Rises 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2648508694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648508694?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:32","pubTimestamp":1782981120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. rallied 3.3% to 16.43 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 23055.03.Sinopharm Group Co. Ltd. closed 26% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 6.6%.Trading volume totaled 5.5 million shares, compared to the 50-day average of 6.9 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 02, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","LU1115378108.SGD","BK0096","600196","BK1593","BK0060","BK0196","BK0175","BK0239","BK1515","BK0012","SHTDY","BK4175","02196","BK0183","BK1197","01099","LU0640798160.USD","BK1191","BK1500","BK0187","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648288575","title":"Shanghai Junshi Biosciences HK Shares Hit 4-week Peak on Fosun's Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2648288575","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648288575?lang=en_us&edition=fundamental","pubTime":"2026-07-02 11:27","pubTimestamp":1782962830,"startTime":"0","endTime":"0","summary":"BUZZ-Shanghai Junshi Biosciences HK shares hit 4-week peak on Fosun's licensing deal** Hong Kong shares of Shanghai Junshi Biosciences1877.HKjump 14.5% to HK$19.06, their highest level since June 2** ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nL1N43402G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0096","600196","00656","BK1161","BK0060","BK0196","BK0175","BK1593","BK0239","BK1515","BK0012","01877","BK1583","02196","BK0183","688180","BK1191","BK1230","BK0187","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648170505","title":"Junshi Biosciences Licenses JS005 Rights in Greater China to Fosun Wanbang for CNY 215 Million Upfront","url":"https://stock-news.laohu8.com/highlight/detail?id=2648170505","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648170505?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:28","pubTimestamp":1782905285,"startTime":"0","endTime":"0","summary":"Junshi Biosciences licenses JS005 rights in Greater China to Fosun Wanbang for CNY 215 million upfrontShanghai Junshi Biosciences signed a Greater China licensing deal with Fosun Pharma unit Fosun Wan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL6MGfg3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0060","BK0012","BK0175","BK0187","BK1230","00656","BK0239","BK0183","600196","BK0196","BK0028","BK0096","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648551552","title":"Shanghai Fosun Pharmaceutical Says Board Approved Appointment of Xingli Wang as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2648551552","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648551552?lang=en_us&edition=fundamental","pubTime":"2026-07-01 16:18","pubTimestamp":1782893891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL4N4330ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0060","BK0096","BK0183","600196","BK0175","BK0187","BK0028","BK0196","BK0012","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648515261","title":"Shanghai Fosun Pharmaceutical's Board Approves President Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2648515261","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648515261?lang=en_us&edition=fundamental","pubTime":"2026-07-01 16:18","pubTimestamp":1782893891,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Fosun Pharmaceutical's Board Approves President AppointmentJuly 1 (Reuters)-Shanghai Fosun Pharmaceutical Group Co Ltd600196.SS:SAYS BOARD APPROVED APPOINTMENT OF XINGLI WANG AS PRESIDENTSource textFurther company coverage:600196.SS","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nL4N4330ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0012","BK0060","BK0028","BK0096","BK0183","BK0187","BK0239","BK0188","BK0196","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647858019","title":"Fosun Pharma to Offload Partnership Fund Stake for 1 Million Yuan; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647858019","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647858019?lang=en_us&edition=fundamental","pubTime":"2026-06-30 14:59","pubTimestamp":1782802785,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  and a subsidiary agreed to dispose of their stake in Jinan Fujian Partnership to Shanghai Fujian, according to a Shanghai bourse filing on Tuesday.Fosun will transfer its subscribed 7 million yuan interest in the partnership fund for 1.1 million yuan, while its subsidiary, Fosun Pingyao, will transfer its 1 million yuan stake for 150,000 yuan.After the transaction, the company will no longer own any equity in Jinan Fujian.The pharmaceutical company's Hong Kong shares dropped 4%, while Shanghai shares fell nearly 2% during the afternoon trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0060","BK0196","BK0096","BK0188","BK0175","BK0187","BK0012","BK1515","600196","BK1593","BK1191","BK0028","02196","BK0183","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647837610","title":"Fosun Pharma's Unit Gets Registration Nod for Spasm, Pain Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2647837610","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647837610?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:30","pubTimestamp":1782732638,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  unit Hebei Wanbang Folon Pharmaceutical obtained approval for the registration application of Shaoyao Gancao Tang Granules from China's National Medical Products Administration.The drug is used for various spasm and pain conditions caused by insufficiency of yin and blood and malnourishment of the sinews and vessels that manifests as leg and feet spasms andabdominal pain, according to a Monday filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK1515","BK0060","BK0012","BK0175","BK1191","BK0239","BK0183","600196","BK0028","BK0196","BK1593","02196","BK0096","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647997378","title":"Shanghai Fosun Pharma - Drug Registration Application for Shaoyao Gancao Tang Granules Approved by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2647997378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647997378?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:05","pubTimestamp":1782727533,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN4310JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0175","BK0096","BK0187","BK0239","BK0183","02196","BK0188","BK0012","BK0028","BK0196","BK1593","BK1515","BK0060","BK1191","600196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784795955541,"stockEarnings":[{"period":"1week","weight":-0.035},{"period":"1month","weight":0.0866},{"period":"3month","weight":-0.0626},{"period":"6month","weight":-0.1306},{"period":"1year","weight":-0.0763},{"period":"ytd","weight":-0.0951}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0711},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0651},{"period":"1year","weight":0.0796},{"period":"ytd","weight":-0.0257}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"上海复星医药(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"1998-08-07","address":"上海市普陀区曹杨路510号9楼","registeredCapital":"267042万元","survey":"　　上海复星医药(集团)股份有限公司的主营业务是制药、医疗器械与医学诊断、医疗健康服务，并通过参股国药控股覆盖到医药商业领域。公司的主要产品是抗肿瘤及免疫调节核心产品、抗感染核心产品、代谢及消化系统核心产品、心血管系统核心产品、中枢神经系统核心产品、原料药和中间体核心产品。根据工信部中国医药工业信息中心颁布的“2024年度中国医药工业百强企业榜单”，本集团位列第5位。此外，在ESG方面，复星医药于报告期内荣登2025《财富》ESG影响力榜单，成为唯一入选该榜单的中国医药企业。根据MSCI于2025年7月公布的ESG年度评级结果，本集团MSCIESG评级提升至AA级。在AI领域，复星医药凭借自主研发的PharmAID医药智能平台荣获福布斯“2025中国人工智能科技创新场景应用企业TOP10”。","listedPrice":7.15},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.,600196,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票老虎,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票老虎国际,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.行情,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票行情,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股价,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股市,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票价格,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票交易,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票购买,Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Fosun Pharmaceutical (Group) Co.,Ltd.(600196) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction